Rosiglitazone in combination with glibenclamide: Effect on PAI-1 antigen, PAI-1 activity, and tPA in patients with type 2 diabetes

التفاصيل البيبلوغرافية
العنوان: Rosiglitazone in combination with glibenclamide: Effect on PAI-1 antigen, PAI-1 activity, and tPA in patients with type 2 diabetes
المؤلفون: BarryJ. Goldstein, MartinI. Freed, Lisa Menci, Heise Ma, Diane Fuell
المصدر: Diabetes Research and Clinical Practice. 50:64
بيانات النشر: Elsevier BV, 2000.
سنة النشر: 2000
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, General Medicine, Type 2 diabetes, medicine.disease, Glibenclamide, Endocrinology, Pai 1 activity, Antigen, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, In patient, Rosiglitazone, business, medicine.drug
تدمد: 0168-8227
DOI: 10.1016/s0168-8227(00)81675-7
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ce5712eeeb66981c261be85cca62dd1f
https://doi.org/10.1016/s0168-8227(00)81675-7
Rights: CLOSED
رقم الانضمام: edsair.doi...........ce5712eeeb66981c261be85cca62dd1f
قاعدة البيانات: OpenAIRE
الوصف
تدمد:01688227
DOI:10.1016/s0168-8227(00)81675-7